23DME, the founder of Anne Wagiki, has just got Greenlight to buy her company for $ 305 million after she lost 98 % of her previous value

This means that the TTAM Institute for Non -Purful Research in WoJCICKI will buy “all of the foundations” of San Francisco based for $ 305 million. The deal – which arrives after more than three months from 23andme It was presented to bankruptcy, Chapter 11 – He was appointed to officially close in the coming weeks.

“I feel overwhelmed because TTAM will be able to build on the 23ndme mission to help people reach, understand and benefit from the human genome.” He said In Monday’s statement – adding later, “The future of health care belongs to all of us.”

The sale, which was approved by the American bankruptcy judge, Brian C, on Friday, is the end of a bidding war for months between TTAM and Regeneron Pharmaceuticals A biotechnology company that has previously agreed to buy Most of 23ndme assets for $ 256 million in May. But the non -profit Wojcicki organization later topped this offer, and won the final round of the bids held last month.

According to the deal, TTAM will get the “Genome Personal Genome Service” from 23andme provided through salivary-based DNA testing groups-in addition to its LEMONAID’s healthy searches, and it is a service provider from a distance from this 23andme dimension. It was previously planned To decline.

WoJCICKI’s work to take your 23ndme for some time. With the company struggling to find a profitable business model since it was launched in 2021, it confirmed that it will work better in market pressure. But this endeavor proved that it is noisy – especially in September last year, when All independent 23ndme managers resigned from the Board of Directors Quoting a “clear” difference in opinion with WojCicki about the company’s future after the negotiated negotiations.

It leads to 23andme’s Bank bankruptcy marchSubsequent efforts from Wojcicki to obtain the company has not succeeded. When 23andme applied to Chapter 11 in late March, Wojcikki resigned as an executive president – noting at the time that she was stepped down to be “in the best position” as an independent bidding.

Now that the non -profit WoJCICKI Foundation has gained 23andme, it is not clear whether the co -founder will return to the seat of the CEO. But despite the removal of the highest months after months, wojcicki remained on the company’s board of directors throughout the bankruptcy process.

behind Financial strains that lead to bankruptcy of 23andme, fears related to privacy have emerged to genetic information to customers – whose history dates back to even before the bankruptcy process, especially with data breach 2023. But anxiety What is the new property that can be concerned with personal data for 23ndme users Launch in recent months. The court documents indicate that the genetic testing company has about 13 million customers at the time of the sale session.

In June, 27 states and province of Colombia litigate Seek to ban the sale of personal genetic data under 23andme without the customer’s approval. In a note that determines his approval to sell 23andme to TTAM on Friday, Walsh admitted that the objections of these states to the acquisition – but this indicated that many have been resolved since then. However, California, Kentucky, Tennessee, Texas, Utah “are still opposed for sale.”

In a statement To politico On Monday, the California Prosecutor’s Office, Rob Punta, confirmed that the sale of 23andme “does not comply with” the state of genetic privacy law in the state – and said it was “disappointed” with the approval of the court, adding that it was establishing the following steps.

Associated Press arrived at the Punta office for more comments on Tuesday.

Upon announcement last month23andme confirmed that TTAM “confirmed its commitment” to compliance with the company’s privacy policies and the applicable law. This means that TTAM will honor the current policies on consumer data, which includes allowing users to delete their data and “cancel the subscription” from the search.

And 23andme said that all customers will be sent by e -mail at least two working day before the acquisition closed – with details of TTAM’s private obligations and instructions on how to delete data or cancel the subscription in the search. The company added that TTAM will provide customers for two years of Experts Monitor the theft of identity without any cost.

23ndme remedy these privacy policies on Monday. “The essence of my beliefs is that individuals should be enabled from choice and transparency in relation to their genetic data and have the opportunity to continue to identify their grandparents and their health risks as they wish,” WojCICKI added.